CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Quanterix Corp is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Quanterix Corp
900 Middlesex Turnpike
Phone: (617) 301-9400p:617 301-9400 BILLERICA, MA  01821  United States Ticker: QTRXQTRX
Business Summary
Quanterix Corporation is engaged in fueling scientific discovery through ultra-sensitive biomarker detection. The Company’s Simoa technology delivers earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the level of quantification (LoQ). Its precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Its products and services include Simoa Assay Kits, Simoa Dry Blood Extraction Kit, LDTs & Assay Services, Instruments, Simoa Accelerator Laboratory, Homebrew-Custom Assay Development, and Nova Beads. LDTs & Assay Services include Simoa p-Tau 217, Simoa NfL LDT, and LucentAD pTau 217. Its instruments include Simoa HD-X Analyzer-Automated Immunoassays, Quanterix SR-X Biomarker Detection System, and SP-X Imaging and Analysis System.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202512/31/2024YesYes--Yes

Industries
SIC Code Description
3826 Laboratory analytical instruments
3845 Electromedical and electrotherapeutic apparatus
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board William P.Donnelly 63 3/24/2025 8/17/2023
President, Chief Executive Officer, Director MasoudToloue 44 4/25/2022 6/9/2021
Chief Financial Officer, Treasurer VandanaSriram 51 8/21/2023 8/21/2023
4 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Akoya Biosciences UK Ltd. 2 Minton Place Victoria Road Bicester United Kingdom
Akoya Biosciences Inc 100 Campus Drive, 6Th Floor MARLBOROUGH MA United States
Emission Inc. 2500 NE Inner Loop Georgetown TX United States

Business Names
Business Name
Akoya Biosciences Inc
Akoya Biosciences UK Ltd.
Akoya Biosciences US Ltd.
10 additional Business Names available in full report.

General Information
Number of Employees: 471 (As of 12/31/2024)
Outstanding Shares: 46,654,879 (As of 7/8/2025)
Shareholders: 18
Stock Exchange: NASD
Federal Tax Id: 208957988
Fax Number: (302) 655-5049


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 11, 2025